Search

Your search keyword '"Jean-Philippe Lanoix"' showing total 69 results

Search Constraints

Start Over You searched for: Author "Jean-Philippe Lanoix" Remove constraint Author: "Jean-Philippe Lanoix"
69 results on '"Jean-Philippe Lanoix"'

Search Results

1. Life threatening rickettsiosis and the role of hemophagocytic lymphohistiocytosis syndrome (HLH): Case report of a 21-year-old woman

2. One Hundred Explicit Definitions of Potentially Inappropriate Prescriptions of Antibiotics in Hospitalized Older Patients: The Results of an Expert Consensus Study

3. Number of initial symptoms is more related to long COVID-19 than acute severity of infection: a prospective cohort of hospitalized patients

4. Plasma Markers of Neutrophil Extracellular Trap Are Linked to Survival but Not to Pulmonary Embolism in COVID-19-Related ARDS Patients

5. Mortality risk and antibiotic use for COVID-19 in hospitalized patients over 80

6. Cytomegalovirus-Associated Gianotti-Crosti Syndrome in 28-Year-Old Immunocompetent Patient

7. Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from France

9. Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis

10. Antiviral drugs in hospitalized patients with COVID-19 - the DisCoVeRy trial

11. Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

12. The Relationship Between Forgiveness and Health Outcomes Among People Living with HIV: A Cross-Sectional Study in France

13. Atypical pneumonia clusters

15. An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 – Final results from the DisCoVeRy trial

16. Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID‐19

17. No Impact of Corticosteroid Use During the Acute Phase on Persistent Symptoms Post-COVID-19

18. Medical versus surgical treatment in native hip and knee septic arthritis

19. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19

20. Author response for 'Influenza vaccination and prognosis of COVID ‐19 in hospitalized patients with diabetes: Results from the CORONADO study'

21. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

22. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

23. Comparison of nasopharyngeal and saliva swabs for the detection of RNA SARS-CoV-2 during mass screening (SALICOV study)

24. Holistic Medicine Must Mean Whole: How to Deal with Spirituality

25. Remdesivir for the Treatment of Hospitalised Patients with COVID-19 (DisCoVeRy): A Randomised, Controlled, Open-Label Trial

26. Which features of an outpatient treatment for COVID-19 would be most important for pandemic control? A modelling study

27. Mutations in fbiD (Rv2983) as a novel determinant of resistance to pretomanid and delamanid in Mycobacterium tuberculosis

28. Trajectories of Hospitalization in COVID-19 Patients: An Observational Study in France

29. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays

30. Characteristics and outcomes of COVID ‐19 in hospitalized patients with and without diabetes

31. Association between renin–angiotensin system inhibitors and COVID-19 complications

32. Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of Mycobacterium avium Infection

33. Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial

34. Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of

35. Effect Of Motivational Team On Influenza Vaccination Coverage Among Health Care Workers

36. In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1

37. Community-acquired granulomatous mastitis superinfected with Mycobacterium bolletii

38. National advisory services for multidrug-resistant tuberculosis (MDRTB) in Europe

39. Treatment as prevention enrolling at least 75% of individuals on ART will be needed to significantly reduce HIV prevalence in a HIV cohort

40. Tolerability and Plasma Drug Level Monitoring of Prolonged Subcutaneous Teicoplanin Treatment for Bone and Joint Infections

41. Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis

42. Mutations in Rv2983 as a novel determinant of resistance to nitroimidazole drugs in Mycobacterium tuberculosis

43. Syndrome de Fanconi chez un patient de 22 ans d’origine africaine

44. Seasonal flu vaccination: a matter of choice?

45. Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of Caseum

46. Assessing Urine Human Papillomavirus Polymerase Chain Reaction Testing As a Tool for Screening Anal HPV Infection in HIV-Positive MSM

47. High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis

48. Traitement de la tuberculose ganglionnaire : des recommandations à la pratique

49. Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?

50. Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives

Catalog

Books, media, physical & digital resources